NCT00433199View on ClinicalTrials.gov

Testosterone Treatment for Hypogonadal Men

PHASE3CompletedINTERVENTIONAL

Enrollment

274

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

April 30, 2008

Conditions

Hypogonadism

Interventions

DRUG

Testosterone (T) Gel 1.62%

Testosterone gel 1.62% contains 1.62% testosterone gel as active ingredient.

DRUG

Placebo

Placebo Control

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY